HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Employees - 226000,
CEO - Mr. Samuel N. Hazen,
Sector - Healthcare,
Country - US,
Market Cap - 83.00B
Altman ZScore(max is 10): 2.6, Piotroski Score(max is 10): 6, Working Capital: $1237000000, Total Assets: $59513000000, Retained Earnings: $-2115000000, EBIT: 10572000000, Total Liabilities: $58958000000, Revenue: $70603000000
AryaFin Target Price - $276.12 - Current Price $337.11 - Analyst Target Price $375.52
Ticker | HCA |
Index | S&P 500 |
Curent Price | 337.11 |
Change | -1.26% |
Market Cap | 83.00B |
Average Volume | 1.68M |
Income | 5.76B |
Sales | 70.60B |
Book Value/Share | -10.00 |
Cash/Share | 8.21 |
Dividend Est | 2.79 (0.83%) |
Dividend TTM | 2.70 (0.80%) |
Dividend Ex-Date | Mar 17, 2025 |
Employees | 316000 |
Moving Avg 20days | 0.20% |
Moving Avg 50days | 2.47% |
Moving Avg 200days | -2.60% |
Shares Outstanding | 249.98M |
Earnings Date | Apr 25 BMO |
Inst. Ownership | 65.71% |
Price/Earnings | 15.33 |
Forwad P/E | 12.08 |
PE Growth | 1.26 |
Price/Sales | 1.18 |
Price/Book | - |
Price/Cash | 41.07 |
Price/FCF | 14.72 |
Quick Ratio | 0.97 |
Current Ratio | 1.08 |
Debt/Equity | - |
Return on Assets | 9.95% |
Return on Equity | - |
Return on Investment | 15.28% |
Gross Margin | 14.94% |
Ops Margin | 14.94% |
Profit Margin | 8.16% |
RSI | 52.53 |
BETA(β) | 1.46 |
From 52week Low | 16.25% |
From 52week High | -19.19% |
EPS | 21.99 |
EPS next Year | 27.92 |
EPS next Qtr | 6.29 |
EPS this Year | 13.43% |
EPS next 5 Year | 12.18% |
EPS past 5 Year | 16.93% |
Sales past 5 Year | 6.69% |
EPS Y/Y | 15.32% |
Sales Y/Y | 8.67% |
EPS Q/Q | -4.95% |
Sales Q/Q | 5.68% |
Sales Surprise | 0.34% |
EPS Surprise | 12.19% |
ATR(14) | 11.36 |
Perf Week | 0.63% |
Perf Month | -0.05% |
Perf Quarter | 7.68% |
Perf Year | 5.53% |
Perf YTD | 12.31% |
Target Price | 375.52 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer